• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性乙型肝炎合并继发性血色素沉着症临床治愈:一例报告

Chronic hepatitis B complicated with secondary hemochromatosis was cured clinically: A case report.

作者信息

Ye Yun, Xie Jing, Wang Lina, He Cong, Tan Youwen

机构信息

Department of Hepatology, The Third Hospital of Zhenjiang Affiliated Jiangsu University, Zhenjiang 212003, Jiangsu Province, China.

出版信息

Open Med (Wars). 2023 Mar 30;18(1):20230693. doi: 10.1515/med-2023-0693. eCollection 2023.

DOI:10.1515/med-2023-0693
PMID:37016704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10066873/
Abstract

Chronic hepatitis B (CHB) often causes iron overload in the liver but rarely causes severe secondary hemochromatosis (SH). A 48-year-old man was infected with CHB via vertical transmission. For 21 years, nonstandard treatment with second-line hepatitis B antiviral drugs has been administered. Repeated abnormalities in the liver transaminase function and continuous low-level replication of the hepatitis B virus (HBV) have been detected. The skin had turned black 5 years back. Biochemical tests and imaging revealed the presence of hemochromatosis. A liver biopsy suggested severe iron overload. Two genetic tests ruled out hereditary hemochromatosis. The patient was diagnosed with SH and treated with 400 ml bloodletting once per week and an iron-chelating agent. After 12 weeks, liver function was normal, and the skin turned white. First, hepatitis B surface antigen (HBsAg) was lost, and HBV DNA was copied at low levels. The patient was diagnosed with an occult hepatitis B infection. HBV DNA was undetectable after 4 weeks of antiviral treatment with tenofovir. Upon reviewing the patient's medical history, hemochromatosis was believed to be related to CHB with chronic inflammatory damage and no complete virological response. Improvements in hemochromatosis may promote HBsAg disappearance.

摘要

慢性乙型肝炎(CHB)常导致肝脏铁过载,但很少引起严重的继发性血色素沉着症(SH)。一名48岁男性通过垂直传播感染了CHB。21年来,一直使用二线乙肝抗病毒药物进行不规范治疗。检测到肝转氨酶功能反复异常以及乙肝病毒(HBV)持续低水平复制。5年前皮肤变黑。生化检查和影像学检查显示存在血色素沉着症。肝脏活检提示严重铁过载。两项基因检测排除了遗传性血色素沉着症。该患者被诊断为SH,并接受每周一次400毫升放血及铁螯合剂治疗。12周后,肝功能恢复正常,皮肤变白。首先,乙肝表面抗原(HBsAg)消失,HBV DNA呈低水平复制。该患者被诊断为隐匿性乙型肝炎感染。使用替诺福韦进行抗病毒治疗4周后,HBV DNA检测不到。回顾患者病史,血色素沉着症被认为与CHB伴慢性炎症损伤且无完全病毒学应答有关。血色素沉着症的改善可能促进HBsAg消失。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/10066873/c6f0338b4b84/j_med-2023-0693-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/10066873/3340a388f0bd/j_med-2023-0693-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/10066873/c6f0338b4b84/j_med-2023-0693-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/10066873/3340a388f0bd/j_med-2023-0693-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/154e/10066873/c6f0338b4b84/j_med-2023-0693-fig002.jpg

相似文献

1
Chronic hepatitis B complicated with secondary hemochromatosis was cured clinically: A case report.慢性乙型肝炎合并继发性血色素沉着症临床治愈:一例报告
Open Med (Wars). 2023 Mar 30;18(1):20230693. doi: 10.1515/med-2023-0693. eCollection 2023.
2
[Clinical characteristics and effect of secondary individualized therapy in chronic hepatitis B patients infected with the rtA181 mutation hepatitis B virus].[rtA181 突变型乙型肝炎病毒感染慢性乙型肝炎患者二次个体化治疗的临床特征及疗效]
Zhonghua Gan Zang Bing Za Zhi. 2012 Apr;20(4):280-4. doi: 10.3760/cma.j.issn.1007-3418.2012.04.011.
3
Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.口服抗病毒治疗期间血清HBV DNA检测不到的慢性乙型肝炎患者肝内总HBV DNA、cccDNA及血清HBsAg水平分析
Clin Res Hepatol Gastroenterol. 2017 Dec;41(6):635-643. doi: 10.1016/j.clinre.2017.03.004. Epub 2017 Apr 21.
4
Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable covalently closed.在共价闭合环状DNA检测不到的慢性乙型肝炎患者中,核苷/核苷酸类似物停药后乙肝病毒DNA的反弹
JHEP Rep. 2020 Mar 29;2(3):100112. doi: 10.1016/j.jhepr.2020.100112. eCollection 2020 Jun.
5
Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection.
J Hepatol. 1992 Nov;16(3):364-8. doi: 10.1016/s0168-8278(05)80671-3.
6
Combination and Intermittent Therapy Based on Pegylated Interferon Alfa-2a for Chronic Hepatitis B with Nucleoside (Nucleotide) Analog-Experienced Resulting in Hepatitis B Surface Antigen Clearance: A Case Report.基于聚乙二醇干扰素 alfa-2a 的联合和间断治疗在核苷(酸)类似物经治后实现乙型肝炎表面抗原清除的慢性乙型肝炎:1 例报告。
Viral Immunol. 2022 Jan-Feb;35(1):71-75. doi: 10.1089/vim.2021.0112. Epub 2021 Oct 28.
7
Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.恩替卡韦治疗的慢性乙型肝炎患者病毒学应答与FIB-4指数的关系
World J Gastroenterol. 2015 Nov 21;21(43):12421-9. doi: 10.3748/wjg.v21.i43.12421.
8
A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B: First-stage results at week 48.一项关于清众(富马酸替诺福韦二吡呋酯)与韦瑞德治疗慢性乙型肝炎的随机、双盲、双模拟、对照、多中心研究:第48周的第一阶段结果
Medicine (Baltimore). 2019 Aug;98(33):e16778. doi: 10.1097/MD.0000000000016778.
9
Individualized treatment of HBeAg-negative chronic hepatitis B using pegylated interferon-α2a as first-line and week-12 HBV DNA/HBsAg stopping rule: a cost-effectiveness analysis.使用聚乙二醇化干扰素-α2a作为一线治疗以及第12周乙肝病毒DNA/乙肝表面抗原停药规则对HBeAg阴性慢性乙型肝炎进行个体化治疗:一项成本效益分析
Antivir Ther. 2013;18(4):623-33. doi: 10.3851/IMP2555. Epub 2013 Mar 13.
10
[Effective antiviral therapy with entecavir in chronic hepatitis B virus carriers].恩替卡韦对慢性乙型肝炎病毒携带者的有效抗病毒治疗
Zhonghua Gan Zang Bing Za Zhi. 2014 Dec;22(12):900-3. doi: 10.3760/cma.j.issn.1007-3418.2014.12.005.

本文引用的文献

1
Identification of novel non-HFE mutations in Chinese patients with hereditary hemochromatosis.鉴定中国遗传性血色素沉着症患者中的新型非 HFE 突变。
Orphanet J Rare Dis. 2022 Jun 6;17(1):216. doi: 10.1186/s13023-022-02349-y.
2
Hemochromatosis risk genotype is not associated with colorectal cancer or age at its diagnosis.血色素沉着症风险基因型与结直肠癌或其诊断时的年龄无关。
HGG Adv. 2020 Aug 25;1(1):100010. doi: 10.1016/j.xhgg.2020.100010. eCollection 2020 Oct 22.
3
Correlation of genotype and phenotype in 32 patients with hereditary hemochromatosis in China.
中国 32 例遗传性血色素沉着症患者基因型与表型的相关性。
Orphanet J Rare Dis. 2021 Sep 28;16(1):398. doi: 10.1186/s13023-021-02020-y.
4
Appropriate Clinical Genetic Testing of Hemochromatosis Type 2-4, Including Ferroportin Disease.2 - 4型血色素沉着症(包括铁转运蛋白病)的适当临床基因检测。
Appl Clin Genet. 2021 Aug 12;14:353-361. doi: 10.2147/TACG.S269622. eCollection 2021.
5
Hemochromatoses.血色素沉着症
J Hepatol. 2021 Sep;75(3):723-724. doi: 10.1016/j.jhep.2021.04.001. Epub 2021 Jul 11.
6
Juvenile haemochromatosis.青少年血色病。
Lancet Child Adolesc Health. 2021 Jul;5(7):524-530. doi: 10.1016/S2352-4642(20)30392-8. Epub 2021 Apr 15.
7
The emerging role of ferroptosis in non-cancer liver diseases: hype or increasing hope?铁死亡在非癌症性肝脏疾病中的新兴作用:炒作还是增加希望?
Cell Death Dis. 2020 Jul 9;11(7):518. doi: 10.1038/s41419-020-2732-5.
8
Diagnosis and management of hereditary haemochromatosis.遗传性血色素沉着症的诊断和治疗。
Vox Sang. 2020 May;115(4):255-262. doi: 10.1111/vox.12896. Epub 2020 Feb 20.
9
Non- mutations in haemochromatosis in China: combination of heterozygous mutations involving signal peptide variants.中国人血色病中无突变:涉及信号肽变异体的杂合突变组合。
J Med Genet. 2018 Oct;55(10):650-660. doi: 10.1136/jmedgenet-2018-105348. Epub 2018 Aug 30.
10
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype.C282Y/C282Y 纯合基因型 HFE 血色病的治疗建议。
Hepatol Int. 2018 Mar;12(2):83-86. doi: 10.1007/s12072-018-9855-0. Epub 2018 Mar 27.